CDH5 and neoplasm: Among these potential targets, VE-cadherin (CDH5) was chosen for further experimental validation, not only because it was identified as a target of miR-27a-3p by all three databases, but also due to its frequent over-expression in tumor tissues and its well-known importance in both tumor invasion and VM formation20, 21.